Pacer Advisors’s Medicines Co MDCO Stock Holding History

Pacer Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,763	Closed	-$257K	–	1274
2017 Q2	$257K	Buy	6,763 +718	+12%	+$32K	0.03%	911
2017 Q1	$296K	Buy	+6,045	New	+$276K	0.04%	760

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors's MDCO Position: Q3 2017 in Review

Pacer Advisors sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 6,763 shares — an estimated $257K sold.

Pacer Advisors first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $296K in Q1 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

Pacer Advisors reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
Pacer Advisors sold 6,763 Medicines Co shares in Q3 2017, an estimated $257K.
Pacer Advisors first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
Pacer Advisors's Medicines Co position peaked at $296K in Q1 2017.
190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Pacer Advisors's 13F filing for Q3 2017, filed 8 Nov 2017.